1.Clinical effect of nanofat on improving superficial rhytides of face and neck and dark lower eyelids
Bofu XIAO ; Zhaoxiang ZHANG ; Lihong QIU ; Hui ZHWNG ; Yingjun SU ; Xianjie MA ; Chenggang YI
Chinese Journal of Medical Aesthetics and Cosmetology 2019;25(1):36-38
Objective To evaluate the clinical effect of nanofat on superficial rhytides of face and neck and dark lower eyelids.Methods From September 2014 to January 2017,a total of 86 cases were collected in our hospital for voluntary nanofat transplantation on superficial rhytides and dark lower eyelids.This was a retrospective study,which included 18 cases of eye wrinkles,14 cases of forehead wrinkles,neck wrinkles in 14 cases,and 22 cases of dark lower eyelids.First of all,we harvested mircofat through liposuction,and then transformed mircofat to nanofat.At last,nanofat was grafted into intradermal layer of the skin with sharp needles.We took the standard photographs of the patients.After six months follow-up,doctors and patients evaluated the short term and long-term postoperative effect.Results No serious complications occurred in all patients.Postoperative evaluation of facial and neck superficial wrinkles showed that the satisfactory rate of doctors and patients after one month,was 85.9%and 84.3%,and after 6 months 87.5% and 84.3%,respectively.Postoperative evaluation of dark lower eyelids showed that the satisfactory rate of doctors and patients after one month was 45.5% and 36.4%,and after 6 months 81.8% and 86.4%,respectively.Conclusions Nanofat can rectify the superficial rhytides of face and neck and dark lower eyelids in some patients.However,for some patients the effect is not satisfied.
2.Correlation between changes of body fat distribution and insulin resistance after Roux-en-Y gastric bypass
Rao LI ; Liyong ZHU ; Pengzhou LI ; Xiangwu YANG ; Weizheng LI ; Guangnian JI ; Xulong SUN ; Xianjie QIU ; Shaihong ZHU
International Journal of Surgery 2018;45(4):228-233
Objective To investigate the effect of laparoscopic Roux-en-Y gastric bypass(LYGB) on body fat distribution,and relationship between the changes of body fat distribution and improvement of insulin resistance.Methods A total of 65 patients with type 2 diabetes who underwent LYGB were selected for a retrospective analysis.Metabolic parameters,anthropometric measurements,body composition and fat distribution measured by dual-energy X-ray absorptiometry (DEXA) were collected separately before and 6 months post LYGB.All data of pre-and postoperation were compared with pair t test,Pearson correlation analysis was used to evaluate correlation of two variables.Results Weight,body mass index,waist circumference,waist-to-hip ratio,triglyceride,fasting plasma glucose,fasting insulin and homeostatic model assessment for insulin resistance (HOMA-IR) were significantly decreased in 6 months after surgery (P < 0.05).Total fat mass,body fat mass of trunk,upper and lower limbs decreased significantly (P <0.05).Percent fat mass at the whole body,Android region,upper and lower limbs decreased significantly (P <0.05).After 6 months postoperatively,abdominal obesity indices waist circumfernce decreased from (98.10±13.03) cm to (91.60±7.68) cm (P<0.01) and percent fat mass at the Android region decreased from (35.71 ±10.24)% to (29.44 ± 12.11) % (P<0.05),HOMA-IR decreased from 3.62 ± 5.18 to 1.79 ± 1.52 (P < 0.05).The improvement of postoperative insulin resistance is positively correlated with the changes in waist circumference (P <0.01) and percent fat mass of Android region (P <0.05).Conclusions The body fat distribution changes after LYGB,change of abdominal fat distribution is positively correlated to the improvement of insulin resistance.
3.Effect of botulinum toxin A on fat breastaugmentation: a preliminary randomized controlled clinical study
Zhaoxiang ZHANG ; Nian SHI ; Lihong QIU ; Shaoheng XIONG ; Xianjie MA ; Chenggang YI
Chinese Journal of Medical Aesthetics and Cosmetology 2021;27(6):459-463
Objective:To explore whether botulinum toxin A (BTX-A) can improve the retention rate of fat transplantation in fat breast augmentation.Methods:Each patient was divided into control side and experimental side according to the random number table in 14 patients studied. The experimental group received autologous fat and BTX-A combined transplantation on both sides of the breast, while the control side only received autologous fat transplantation. The fat was added with the same volume of normal saline as BTX-A in the control group. All patients were followed up and the effects of BTX-A were evaluated objectively via the comparison of the remained bilateral fat graft volumes that were obtained through a digital three-dimensional reconstructions technique. Moreover, the improvement of each breast appearance and complication were assessed by the physician and patients who were blinded to the recipient treatment assignment.Results:The outcome of the fat breast augmentation was evident for both groups at the follow-up with no evidence of fat embolism, vascular/nervous injury, infection and prolonged bruising. In one of the 14 patients (control group), fat liquefaction necrosis occurred in one side of the breast; after active treatment, it returned to normal, and three patients had different degrees of mass. The analysis on the three-dimensional reconstruction data and the assessments from both the physicians and patients showed significant differences in the fat graft retention volume between the BTX-A group (51.10±20.56)% and the control group (33.06±14.77)%. Nevertheless, there was no significant difference in the incidence of complications between the two sides.Conclusions:Autogenous fat breast augmentation is safe and effective. This study result has shown that BTX-A can significantly improve the retention rate of fat transplantation but cannot reduce the incidence of complications.